Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorHARRIS, Stewart B
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorMOHAMMEDI, Kamel
dc.contributor.authorBERTOLINI, Monica
dc.contributor.authorCARLYLE, Maureen
dc.contributor.authorWALKER, Valery
dc.contributor.authorZHOU, Fang Liz
dc.contributor.authorANDERSON, John E
dc.contributor.authorSEUFERT, Jochen
dc.date.accessioned2023-11-06T14:15:16Z
dc.date.available2023-11-06T14:15:16Z
dc.date.issued2023-09-25
dc.identifier.issn1463-1326en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/184630
dc.description.abstractEnPatient- and physician-associated barriers impact the effectiveness of basal insulin (BI) titration in the management of type 2 diabetes (T2D). We evaluated the experiences of patients with T2D and physicians with BI titration education. In this observational, cross-sectional study, patients with T2D and physicians treating patients with T2D were identified by claims in the Optum Research Database and were invited to complete a survey. Eligible patients had 12 months of continuous health-plan enrolment with medical and pharmacy benefits during the baseline period, and recent initiation of BI therapy. Eligible physicians had initiated BI for ≥1 eligible patient with T2D during the past 6 months. In total, 416 patients and 386 physicians completed the survey. Ninety per cent of physicians reported treating ≥50 patients with T2D; 66% treated ≥25% of patients with BI. Whereas 74% of patients reported that BI titration was explained to them by a physician, 96% of physicians reported doing so. Furthermore, 20% of patients stated they were offered educational materials whereas 56% of physicians reported having provided materials. Physicians had higher expectations of glycaemic target achievement than were seen in the patient survey; their main concern was the patients' ability to titrate accurately (79%). There is a marked difference in patients' and physicians' experiences of BI titration education. Novel tools and strategies are required to enable effective BI titration, with more educational resources at the outset, and ongoing access to tools that provide clear, simple direction for self-titration with less reliance on physicians/health care providers.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectArticle clinique
dc.subject.enbasal insulin; glycaemic control; hypoglycaemia; observational study; type 2 diabetes
dc.title.enPatient and physician perspectives and experiences of basal insulin titration in type 2 diabetes in the United States: Cross-sectional surveys.
dc.title.alternativeDiabetes Obes Metaben_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1111/dom.15240en_US
dc.subject.halSciences du Vivant [q-bio]/Médecine humaine et pathologieen_US
dc.identifier.pubmed37749746en_US
bordeaux.journalDiabetes, Obesity and Metabolismen_US
bordeaux.hal.laboratoriesBiologie des maladies cardiovasculaires (BMC) - UMR 1034en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.identifierhal-04272177
hal.version1
hal.date.transferred2023-11-06T14:15:18Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Diabetes,%20Obesity%20and%20Metabolism&rft.date=2023-09-25&rft.eissn=1463-1326&rft.issn=1463-1326&rft.au=HARRIS,%20Stewart%20B&MOHAMMEDI,%20Kamel&BERTOLINI,%20Monica&CARLYLE,%20Maureen&WALKER,%20Valery&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée